Future research in ITP : an ICIS consensus
(2010) In Annals of Hematology 89(Suppl 1). p.19-23- Abstract
While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/65acd897-a4e1-42fd-bdc6-b1bdf263b411
- author
- Zehnder, James L ; Semple, John W LU ; Imbach, Paul ; Neufeld, Ellis J ; Buchanan, George R and Cines, Douglas B
- author collaboration
- publishing date
- 2010-07
- type
- Contribution to journal
- publication status
- published
- keywords
- Adult, Age Factors, Animals, Child, Disease Models, Animal, Disease Progression, Helicobacter Infections, Helicobacter pylori, Humans, Molecular Targeted Therapy, Purpura, Thrombocytopenic, Idiopathic, Journal Article
- in
- Annals of Hematology
- volume
- 89
- issue
- Suppl 1
- pages
- 5 pages
- publisher
- Springer
- external identifiers
-
- pmid:20309690
- scopus:77955657705
- ISSN
- 1432-0584
- DOI
- 10.1007/s00277-010-0917-1
- language
- English
- LU publication?
- no
- id
- 65acd897-a4e1-42fd-bdc6-b1bdf263b411
- date added to LUP
- 2016-09-23 12:06:34
- date last changed
- 2024-01-04 13:09:45
@article{65acd897-a4e1-42fd-bdc6-b1bdf263b411, abstract = {{<p>While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.</p>}}, author = {{Zehnder, James L and Semple, John W and Imbach, Paul and Neufeld, Ellis J and Buchanan, George R and Cines, Douglas B}}, issn = {{1432-0584}}, keywords = {{Adult; Age Factors; Animals; Child; Disease Models, Animal; Disease Progression; Helicobacter Infections; Helicobacter pylori; Humans; Molecular Targeted Therapy; Purpura, Thrombocytopenic, Idiopathic; Journal Article}}, language = {{eng}}, number = {{Suppl 1}}, pages = {{19--23}}, publisher = {{Springer}}, series = {{Annals of Hematology}}, title = {{Future research in ITP : an ICIS consensus}}, url = {{http://dx.doi.org/10.1007/s00277-010-0917-1}}, doi = {{10.1007/s00277-010-0917-1}}, volume = {{89}}, year = {{2010}}, }